Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18136214 | 0.99 | ANPEP (0.34) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL26077297 | 0.96 | TDP2 (0.34) | ANPEPDPP4TDP2 | |
| SCHEMBL12691343 | 0.92 | ANPEP (0.36) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL819167 | 0.90 | ANPEP (0.33) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL18068730 | 0.90 | ANPEP (0.33) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL15493904 | 0.89 | ANPEP (0.36) | ANPEPDPP4MEN1KMT2AHSD17B10 | |
| SCHEMBL20835100 | 0.88 | CA9 (0.34) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL25688434 | 0.87 | ANPEP (0.39) | ANPEPDPP4MEN1KMT2AKDM4E | |
| SCHEMBL26490051 | 0.87 | ANPEP (0.32) | ANPEPDPP4 | |
| SCHEMBL822115 | 0.86 | ANPEP (0.33) | ANPEPDPP4MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9718031-B2 | Composite hollow fiber membranes useful for CO2 removal from natural gas | CHEVRON U.S.A. INC. (US) | 2017-08-01 | — | — | US | disclosed |
| US-20150011815-A1 | COMPOSITE HOLLOW FIBER MEMBRANES USEFUL FOR CO2 REMOVAL FROM NATURAL GAS | GEORGIA TECH RESEARCH CORPORATION (US) | 2015-01-08 | — | — | US | disclosed |
| US-8449651-B2 | Methods of preparing a crosslinked fiber membrane | CHEVRON U.S.A. INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-8328906-B2 | Method of making a crosslinked fiber membrane from a high molecular weight, monoesterified polyimide polymer | CHEVRON U.S.A. INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120067208-A1 | METHOD OF MAKING A CROSSLINKED FIBER MEMBRANE FROM A HIGH MOLECULAR WEIGHT, MONOESTERIFIED POLYIMIDE POLYMER | GEORGIA TECH RESEARCH CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120048107-A1 | METHODS OF PREPARING A CROSSLINKED FIBER MEMBRANE | CHEVRON U.S.A. INC. | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011815-A1 | COMPOSITE HOLLOW FIBER MEMBRANES USEFUL FOR CO2 REMOVAL FROM NATURAL GAS | C9, HRH3, C5 | ANPEP 4033/4885DPP4 4069/4885MEN1 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.